Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NLRP14 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
mRNA | CCDC129 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
mRNA | TECTA | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
mRNA | HTR5A | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
mRNA | IPO4 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
mRNA | TCF20 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
mRNA | RP11-51F16.8 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
mRNA | WDR60 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
mRNA | ZADH2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
mRNA | PRSS45 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |